F Stogbauer
Overview
Explore the profile of F Stogbauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
506
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Safi S, Krzykalla J, Hoffmann H, Benner A, Bischoff H, Eichhorn M, et al.
Pulmonology
. 2024 Apr;
31(1):2416803.
PMID: 38614857
Introduction And Objectives: Adjuvant platinum-based chemotherapy for completely resected non-small cell lung cancer is associated with modest improvement in survival; nevertheless, no validated biomarker exists for predicting the benefit or...
2.
Meuleman J, Kuhlenbaumer G, Schirmacher A, Wehnert M, Young P, Stogbauer F, et al.
Ann N Y Acad Sci
. 2017 Nov;
883(1):443-444.
PMID: 29086982
No abstract available.
3.
Dogan Onugoren M, Deuretzbacher D, Haensch C, Hagedorn H, Halve S, Isenmann S, et al.
J Neurol Neurosurg Psychiatry
. 2014 Oct;
86(9):965-72.
PMID: 25300449
Background: Two novel antibodies (abs) directed to γ-aminobutyric acid B receptor (GABA(B)R) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) in patients with limbic encephalitis (LE) were first described by the Philadelphia/Barcelona groups...
4.
Riemann B, Stogbauer F, Kopka K, Halfter H, Lasic M, Schirmacher A, et al.
Eur J Nucl Med
. 2014 Mar;
27(12):1870.
PMID: 24578011
No abstract available.
5.
Kellinghaus C, Berning S, Stogbauer F
Acta Neurol Scand
. 2013 Aug;
129(5):294-9.
PMID: 23937330
Objectives: To compare intravenous phenytoin (PHT) and intravenous lacosamide (LCM) for treatment of status epilepticus after failure of the first and second drug. Methods: We retrospectively identified patients from a...
6.
Sporrer D, Weber M, Wanninger J, Weigert J, Neumeier M, Stogbauer F, et al.
Eur J Clin Invest
. 2009 Jun;
39(8):671-9.
PMID: 19490068
Background: CD163 is a monocyte/macrophage specific receptor whose soluble form (sCD163) is elevated in inflammatory diseases. Obesity is associated with chronic inflammation and low adiponectin, an anti-inflammatory adipokine. Adiponectin, 5-aminoimidazole-4-carboxamide-1-4-ribofuranoside...
7.
Young P, De Jonghe P, Stogbauer F, Butterfass-Bahloul T
Cochrane Database Syst Rev
. 2008 Feb;
(1):CD006052.
PMID: 18254090
Background: Charcot-Marie-Tooth disease (CMT) comprises a large variety of different forms of motor and sensory neuropathies. The most frequent are demyelinating forms (CMT1) and axonal forms (CMT2). The molecular basis...
8.
Wiest T, Herrmann O, Stogbauer F, Grasshoff U, Enders H, Koch M, et al.
Clin Genet
. 2006 Jul;
70(1):71-2.
PMID: 16813608
No abstract available.
9.
Kuhlenbaumer G, Berger K, Huge A, Lange E, Kessler C, John U, et al.
J Neurol Neurosurg Psychiatry
. 2006 Mar;
77(4):521-4.
PMID: 16543535
Genetic fine mapping of the first locus identified for genetically complex forms of stroke, STRK1 (which has been mapped to chromosome 5q12 in Icelandic families), has identified the phosphodiesterase 4D...
10.
Schwaag S, Evers S, Schirmacher A, Stogbauer F, Ringelstein E, Kuhlenbaumer G
Cephalalgia
. 2006 Jan;
26(2):158-61.
PMID: 16426270
Mutations in the NOTCH3 gene cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Exons 3 and 4 are mutation hotspots. Migraine is a clinical hallmark of CADASIL....